Ensysce Biosciences (ENSC) Short Interest Ratio & Short Volume $8.10 +0.15 (+1.89%) (As of 12/20/2024 05:16 PM ET) Add Compare Share Share Short Interest Stock AnalysisChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestTrends Ensysce Biosciences Short Interest DataEnsysce Biosciences (ENSC) has a short interest of 115,300 shares. This marks a -97.62% decrease in short interest from the previous month. The short interest ratio (days to cover) is 0.1, indicating that it would take 0.1 days of the average trading volume of 531,202 shares to cover all short positions.Current Short Interest115,300 sharesPrevious Short Interest4,850,000 sharesChange Vs. Previous Month-97.62%Dollar Volume Sold Short$854,373.00Short Interest Ratio0.1 Days to CoverLast Record DateNovember 30, 2024Outstanding Shares1,306,000 sharesPercentage of Shares Shorted8.83%Today's Trading Volume154,888 sharesAverage Trading Volume531,202 sharesToday's Volume Vs. Average29% Short Selling Ensysce Biosciences? Sign up to receive the latest short interest report for Ensysce Biosciences and its competitors with MarketBeat's FREE newsletter. Email Address Skip Charts & View Short Interest HistoryShort Interest ChartDays to Cover ChartShort Percent of Float ChartENSC Short Interest Over TimeENSC Days to Cover Over TimeENSC Percentage of Float Shorted Over Time Ad Crypto 101 MediaThe #1 Coin for November 2024Grayscale Investments just announced a new fund offering access to a HOT new DeFi coin… And thanks to this newly established trust, I believe this coin could skyrocket up to 150x+ in the next 30 days alone! I've compiled everything you need to know about this once-in-a-lifetime DeFi project into a brand-new comprehensive guide… You can get access to the report by clicking here now… Ensysce Biosciences Short Interest History Export to ExcelReport DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date 11/30/2024115,300 shares $854,373.00 -97.6%N/A0.1 $7.41 11/15/20244,850,000 shares $3.25 million -23.6%N/A0.2 $0.67 10/31/20246,350,000 shares $3.66 million +5,514.5%43.4%0.2 $0.58 10/15/2024113,100 shares $19,046.04 -37.2%0.8%0 $0.17 9/30/2024180,200 shares $43,248.00 -11.4%1.6%0.1 $0.24 9/15/2024203,300 shares $66,275.80 -70.5%1.9%0.1 $0.33 Get the Latest News and Ratings for ENSC and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Ensysce Biosciences and its competitors with MarketBeat's FREE daily newsletter. 8/31/2024689,400 shares $272,313.69 +3,885.0%6.3%0.4 $0.40 8/15/202417,300 shares $6,802.36 -92.7%0.2%0.2 $0.39 7/31/2024235,500 shares $105,975.00 +2.5%3.2%1.7 $0.45 7/15/2024229,800 shares $106,052.70 -16.6%3.2%1.7 $0.46 6/30/2024275,500 shares $139,540.75 +4.0%3.8%2 $0.51 6/15/2024264,800 shares $137,696.00 +37.1%3.6%1.8 $0.52 5/31/2024193,200 shares $111,090.00 +40.0%2.7%1.4 $0.58 5/15/2024138,000 shares $85,435.80 +1,337.5%1.9%0.9 $0.62 4/30/20249,600 shares $5,679.36 +134.2%0.1%0 $0.59 4/15/20244,100 shares $2,785.95 -76.6%0.1%0 $0.68 3/31/202417,500 shares $13,828.50 -69.0%0.6%0 $0.79 3/15/202456,500 shares $44,838.40 -34.4%1.9%0 $0.79 2/29/202486,100 shares $80,279.64 +40.9%3.0%0.1 $0.93 2/15/202461,100 shares $54,379.00 -91.0%2.1%0 $0.89 1/31/2024678,500 shares $1.10 million +175.5%23.3%0.5 $1.62 1/15/2024246,300 shares $337,431.00 +9.1%8.8%0.2 $1.37 12/31/2023225,700 shares $239,242.00 +35.2%8.0%1 $1.06 12/15/2023167,000 shares $185,370.00 +25.3%5.9%0.8 $1.11 11/30/2023133,300 shares $151,962.00 +96.6%4.8%0.9 $1.14 11/15/202367,800 shares $59,806.38 +11.3%2.4%0.9 $0.88 10/31/202360,900 shares $56,094.99 +161.4%2.2%0.8 $0.92 10/15/202323,300 shares $33,552.00 +9.9%0.9%0.3 $1.44 9/30/202321,200 shares $29,256.00 -20.0%0.8%0.4 $1.38 9/15/202326,500 shares $46,375.00 -4.0%1.1%0.1 $1.75 8/31/202327,600 shares $51,060.00 -2.1%1.1%0.1 $1.85 8/15/202328,200 shares $54,990.00 -36.8%1.0%0.1 $1.95 7/31/202344,600 shares $89,646.00 +81.3%1.9%0.1 $2.01 7/15/202324,600 shares $48,216.00 +24.9%1.4%0 $1.96 6/30/202319,700 shares $36,051.00 -2.5%2.4%0 $1.83 6/15/202320,200 shares $47,470.00 +6.3%2.5%0 $2.35 5/31/202319,000 shares $45,030.00 -83.3%2.3%0 $2.37 5/15/2023113,600 shares $349,888.00 +43.8%11.0%0.2 $3.08 4/30/202379,000 shares $296,250.00 +62.2%6.3%0.1 $3.75 4/15/202348,700 shares $194,366.57 +5.9%3.9%0.2 $3.99The #1 Coin for November 2024 (Ad)Grayscale Investments just announced a new fund offering access to a HOT new DeFi coin… And thanks to this newly established trust, I believe this coin could skyrocket up to 150x+ in the next 30 days alone! I've compiled everything you need to know about this once-in-a-lifetime DeFi project into a brand-new comprehensive guide… You can get access to the report by clicking here now… 3/31/202346,000 shares $2.68 million -92.1%6.9%0.2 $58.32 3/15/2023580,700 shares $351,904.20 +194.3%17.3%0.3 $0.61 2/28/2023197,300 shares $96,479.70 -28.3%5.7%0.1 $0.49 2/15/2023275,200 shares $167,872.00 -47.6%7.2%0.1 $0.61 1/31/2023525,000 shares $367,500.00 +631.2%9.9%0.2 $0.70 1/15/202371,800 shares $55,321.90 -9.9%1.6%0 $0.77 12/30/202279,700 shares $59,775.00 -44.4%1.7%0.1 $0.75 12/15/2022143,400 shares $131,340.06 -54.6%7.1%0.1 $0.92 11/30/2022315,700 shares $915,530.00 +128.9%17.3%0.3 $2.90 11/15/2022137,900 shares $297,864.00 -8.1%7.5%0.2 $2.16 10/31/2022150,000 shares $484,500.00 -78.5%10.1%0.8 $3.23 10/15/2022698,700 shares $144,630.90 -39.8%3.2%0.5 $0.21 9/30/20221,160,000 shares $249,400.00 -27.5%5.3%1.1 $0.22 9/15/20221,600,000 shares $551,840.00 +134.6%7.4%1 $0.34 8/31/2022681,900 shares $288,034.56 -5.0%3.3%0.5 $0.42 8/15/2022717,500 shares $350,211.75 +30.6%3.5%0.6 $0.49 7/31/2022549,200 shares $282,783.08 -12.1%2.9%0.5 $0.51 7/15/2022624,900 shares $365,628.99 +20.0%3.3%0.5 $0.59 6/30/2022520,600 shares $452,089.04 +45.0%2.9%0.4 $0.87 6/15/2022359,100 shares $169,136.10 +52.9%2.0%0.4 $0.47 5/31/2022234,800 shares $131,652.36 +94.7%1.5%0.2 $0.56 5/15/2022120,600 shares $81,007.02 -83.4%0.9%0.1 $0.67 4/30/2022724,300 shares $796,730.00 +65.0%7.6%0.9 $1.10 4/15/2022439,000 shares $469,730.00 +41.5%4.6%0.6 $1.07 3/31/2022310,200 shares $353,628.00 +139.7%4.0%0.3 $1.14 3/15/2022129,400 shares $139,752.00 -64.0%1.7%0.1 $1.08 2/28/2022359,300 shares $402,416.00 +154.5%4.7%0.1 $1.12 2/15/2022141,200 shares $211,800.00 -59.6%1.8%0 $1.50 1/31/2022349,700 shares $608,478.00 +229.9%4.5%0 $1.74 1/15/2022106,000 shares $347,680.00 -86.8%N/A0 $3.28 12/31/2021801,600 shares $3.77 million -7.7%10.4%0.1 $4.70 12/15/2021868,100 shares $3.57 million +702.3%11.2%0.1 $4.11 11/30/2021108,200 shares $170,956.00 +18.1%1.4%0 $1.58 11/15/202191,600 shares $196,024.00 -58.3%1.2%0.1 $2.14 10/29/2021219,900 shares $483,780.00 +140.3%2.8%0.2 $2.20 10/15/202191,500 shares $216,855.00 -38.8%1.2%0 $2.37 9/30/2021149,400 shares $452,682.00 +280.2%1.6%0.1 $3.03 9/15/202139,300 shares $120,651.00 -20.1%0.4%0 $3.07 8/31/202149,200 shares $155,472.00 +59.7%0.5%0 $3.16 8/13/202130,800 shares $101,024.00 No Change0.3%0 $3.28 ENSC Short Interest - Frequently Asked Questions What is Ensysce Biosciences' current short interest? Short interest is the volume of Ensysce Biosciences shares that have been sold short but have not yet been closed out or covered. As of November 30th, investors have sold 115,300 shares of ENSC short. Learn More on Ensysce Biosciences' current short interest. Is Ensysce Biosciences' short interest increasing or decreasing? Ensysce Biosciences saw a decrease in short interest during the month of November. As of November 30th, there was short interest totaling 115,300 shares, a decrease of 97.6% from the previous total of 4,850,000 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment. How does Ensysce Biosciences' short interest compare to its competitors? Here is how the short interest of companies in the industry of "pharmaceutical products" compare to Ensysce Biosciences: Incannex Healthcare Inc. (0.21%), RAPT Therapeutics, Inc. (3.92%), RenovoRx, Inc. (0.38%), ProMIS Neurosciences, Inc. (0.70%), Forte Biosciences, Inc. (16.50%), NextCure, Inc. (0.24%), KALA BIO, Inc. (0.70%), Daré Bioscience, Inc. (0.65%), DURECT Co. (3.46%), Longeveron Inc. (21.64%), Which stocks are the most shorted right now? As of the most recent reporting period, the following stocks had the largest short interest positions: AppLovin Co. ($5.70 billion), Charter Communications, Inc. ($4.55 billion), Spotify Technology S.A. ($3.84 billion), Royal Caribbean Cruises Ltd. ($3.07 billion), International Paper ($3.00 billion), Coinbase Global, Inc. ($2.93 billion), Cencora, Inc. ($2.54 billion), Paychex, Inc. ($2.53 billion), SoFi Technologies, Inc. ($2.24 billion), and Reddit, Inc. ($2.00 billion). View all of the most shorted stocks. What does it mean to sell short Ensysce Biosciences stock? Short selling ENSC is an investing strategy that aims to generate trading profit from Ensysce Biosciences as its price is falling. ENSC shares are trading up $0.15 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit. How does a short squeeze work against Ensysce Biosciences? A short squeeze for Ensysce Biosciences occurs when it has a large amount of short interest and its stock increases in price. This forces short sellers to cover their short interest positions by buying actual shares of ENSC, which in turn drives the price of the stock up even further. How often is Ensysce Biosciences' short interest reported? Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including ENSC, twice per month. The most recent reporting period available is November, 30 2024. More Short Interest Resources from MarketBeat Related Companies Incannex Healthcare Short Interest RAPT Therapeutics Short Interest RenovoRx Short Interest ProMIS Neurosciences Short Interest Forte Biosciences Short Interest NextCure Short Interest KALA BIO Short Interest Daré Bioscience Short Interest DURECT Short Interest Longeveron Short Interest Short Interest Tools Stocks to Short Largest Short Interest Positions Short Interest Increases Short Interest Decreases Short Interest Reporting Dates This page (NASDAQ:ENSC) was last updated on 12/22/2024 by MarketBeat.com Staff From Our PartnersDid You See Trump’s Bombshell Exec. Order 001?Starting with what I call Exec. Order 001. It’s a bombshell law that I believe Trump will sign within minut...Banyan Hill Publishing | SponsoredWARNING: “Buffett Indicator” flashing for first time in 50 yearsWarren Buffett has sold a staggering $97 billion worth of stocks this year... But why? Our research indi...Behind the Markets | SponsoredRare "crisis signal" triggers for third time in U.S. marketA rare pattern has just repeated for the third time in U.S. history. The last two times this happened, the...Stansberry Research | SponsoredCould This Tiny Device Help You Make an Extra $30k a Year?I believe it’s going to power Elon Musk’s next AI revolution… A revolution he believes will be worth more t...Brownstone Research | SponsoredURGENT: This Altcoin Opportunity Won’t Wait – Act NowAltcoin season moves fast, and those who hesitate are left behind. The window is closing.Crypto Swap Profits | SponsoredHOTTEST TRADER IN AMERICA 🔥🔥🔥Ready for a rocket ride this weekend? After alerting his readers to a tiny $2 stock called Bright Minds Bio...Timothy Sykes | SponsoredBuffett's Oil Bet + This 22% Dividend PlayWarren Buffett has been quietly amassing a massive position in oil stocks. But while Buffett's picks (Occid...Investors Alley | SponsoredBuy this coin BEFORE Inauguration Day …Mark my words … Bitcoin is going to $100,000. BEFORE Trump is inaugurated. And I think it could reach $1...Weiss Ratings | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Ensysce Biosciences, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Ensysce Biosciences With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
